Journal Logo

Articles by M. Egyed

LONG TERM FOLLOW-UP OF PNH PATIENTS TREATED WITH THE SMART ANTI-HC5 ANTIBODY (SKY59/RO7112689) IN THE OPEN LABEL EXTENSION (OLE) OF THE COMPOSER TRIAL: PF348

Röth, A.; Nagy, Z.; de Latour, Peffault R.; More

HemaSphere. 3:125-126, June 2019.

MAINTENANCE OF RESPONSE IN LONG-TERM TREATMENT WITH ROPEGINTERFERON ALFA-2B (BESREMI®) VS. HYDROXYUREA IN POLYCYTHEMIA VERA PATIENTS (PROUD/CONTINUATION-PV PHASE III TRIALS): PS1457

Gisslinger, H.; Klade, C.; Georgiev, P.; More

HemaSphere. 3:670-671, June 2019.